Yoram Bibring, Chief Financial Officer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 8,500 shares at $3.04 ($26K) on 2015-08-20, disclosed to the SEC on 2015-08-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |